REGISTRATION CLOSED
[Past Event] How Investment in Open Innovation Can Lead Us to More Accessible Health Care
Join Worth for an intimate conversation with Cook Stone about this new approach to the at-home environment, how indoor routines are informing consumersโ lives and how brands can capitalize on consumersโ joy-driven purchasing.
The public health emergency around COVID-19 has shown that substantial stakeholder (both government and private) funding to de-risk clinical development, manufacturing development, drug supply security and commercialization can incentivize the industry to cooperatively act to develop vaccines, therapies, diagnostics and treatment regimens more quickly than ever before. These stakeholder incentives for collaboration and open innovation can replace traditional intellectual property rewards for biopharmaceutical R&D. The industry already adopted elements of these factors in CivicaRx, Just Biotherapeutics (no longer independent), Audacity Therapeutics, Medicines4Kids (M4K) and others. Join Worth, Kathleen Entwistle, Paul Fehlner, Barbara Handelin and other special guests as we explore how open innovation in medicine will change the future of healthcare.
Featuring: Kathleen Entwistle, Private Wealth Advisor, Morgan Stanley Private Wealth Management, Paul Fehlner, Co-founder & President/CEO, reVision Therapeutics, Inc. and Barbara Handelin, PHD, Co-Founder & CEO, Audacity Therapeutics, PBC
Moderated by: Juliet Scott-Croxford, CEO, Worth
REGISTRATION CLOSED
Thursday, January 7, 12 p.m. ET/ 9 a.m. PT
Zoom
Private Wealth Advisor, Morgan Stanley Private Wealth Management
President & CEO, reVision Therapeutics, Inc.
CoFounder, CEO, Audacity Therapeutics, PBC
CEO, Worth
Business & Finance
Hinckley and MJM say the money saved them. The rest of the waterfront wants to know what the buyers are really after.
Business & Finance
Atlas Merchant Capital's Larry Kantor sees 75 more basis points and a crash he can't time. Bob Diamond sees a strong economy underneath it all. Both say stay invested.
Business & Finance
Family offices now control more capital than the entire global venture capital industry and are closing in on private equity.
Business & Finance
RIAs are increasingly using annuities as a financial tool to drive tax advantages for their high-net-worth clients.
"*" indicates required fields